M&G plc’s CONMED CNMD Stock Holding History

M&G plc’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-132,132	Closed	-$9.12M	–	416
2024 Q2	$9.12M	Buy	+132,132	New	+$9.64M	0.04%	214

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

M&G plc's CNMD Position: Q3 2024 in Review

M&G plc sold out of CONMED (CNMD) in Q3 2024, closing a stake of 132,132 shares — an estimated $9.12M sold.

M&G plc first reported a position in CNMD in Q2 2024 and held it in 1 quarter. The position peaked at $9.12M in Q2 2024. 290 funds tracked by Wall St. Rank hold CNMD as of Q3 2024.

M&G plc reported no remaining CONMED position as of Q3 2024 after selling out during the quarter.
M&G plc sold 132,132 CONMED shares in Q3 2024, an estimated $9.12M.
M&G plc first reported a position in CONMED in Q2 2024 and held it in 1 quarter.
M&G plc's CONMED position peaked at $9.12M in Q2 2024.
290 funds tracked by Wall St. Rank held CONMED as of Q3 2024.

Based on M&G plc's 13F filing for Q3 2024, filed 31 Oct 2024.